Johnson & Johnson units apart $8.9 billion to settle talc claims; top off 3%

Johnson & Johnson inventory rose greater than 3% within the prolonged session Tuesday after the corporate stated it has proposed to pay as much as $8.9 billion over 25 years to settle claims linked with cosmetic-talc litigation.

Johnson & Johnson
JNJ,
+1.05%
stated in a submitting Tuesday that its subsidiary LTL Management LLC, which manages the authorized wrangling, has re-filed for voluntary Chapter 11 chapter safety as a way to receive approval of a reorganization plan that may “equitably and efficiently resolve all claims arising from cosmetic talc litigation” in opposition to the corporate.

The firm stated it agreed to contribute the $8.9 billion to resolve “all the current and future talc claims” linked with its well-known Johnson’s Baby Powder and different merchandise containing talc. That’s a rise of $6.9 billion over the $2 billion beforehand dedicated in reference to LTL’s preliminary chapter submitting in October 2021, the corporate stated.

The subsidiary additionally has commitments from greater than 60,000 claimants to assist resolutions on these phrases, Johnson & Johnson stated, including that neither LTL’s authentic submitting nor Tuesday’s re-filing are an admission of wrongdoing, nor “an indication that the company has changed its longstanding position that its talcum powder products are safe” and believes the claims to be “specious and lack scientific merit.”

A federal appeals court docket in January rejected the patron merchandise and drug maker’s transfer to put its talc liabilities out of business, saying that the subsidiary was not in monetary misery.

Johnson & Johnson has confronted 1000’s of lawsuits alleging that beauty talc in its merchandise was linked to cancers, asbestos poisoning and different sicknesses.

Shares of Johnson & Johnson have misplaced 10% prior to now 12 months, matching losses for the S&P 500 index
SPX,
-0.58%
in the identical interval.

Source web site: www.marketwatch.com

Rating
( No ratings yet )
Loading...